New Treatment Approaches Valuable For Cancer Pain, Quality Of Life
High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer
Implantable Drug Delivery Device Offers Better Pain Relief
New Drug Reverses Damage To Liver In Stem Cell Transplant
New Approach To Replacing Immune Cells Shrinks Tumors
IL13-PE38 Looks Promising In Early Tests Against Gioma
US Oncology Begins Trial Of Taxotere And Xeloda
Clinical Trials Approved In August 2002 By NCI
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - ACOG says it will no longer accept federal funding
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - All federal grants must be reviewed by Trump appointees, executive order directs